David Lebeaux
Impact in
- Microbiology top 0.05%
- Actinomycetales infections and treatment
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Antimicrobial Resistance in Staphylococcus
Papers in
- Microbiology 33
- Actinomycetales infections and treatment 33
-
- Central Venous Catheters and Hemodialysis 24
- Co-authors
- Christophe Beloin (17 shared papers)Jean‐Marc Ghigo (17 shared papers)Ashwini Chauhan (5 shared papers)Olaya Rendueles (1 shared paper)Olivier Lortholary (21 shared papers)D. Sène (2 shared papers)Claus Ernst Moser (1 shared paper)Klaus Kirketerp‐Møller (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (10 papers)Clinical Infectious Diseases (8 papers)Clinical Microbiology and Infection (7 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)Journal of Infection (4 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
David Lebeaux
153 papers receiving 11.5k citations
David Lebeaux's Hit Papers
Peers
Comparison fields: 5 of 152
- Microbiology 815
- Infectious Diseases 4.5k
- Immunology 1.4k
- Emergency Medical Services 364
- Molecular Medicine 354
Countries citing papers authored by David Lebeaux
This map shows the geographic impact of David Lebeaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lebeaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lebeaux more than expected).
Fields of papers citing papers by David Lebeaux
This network shows the impact of papers produced by David Lebeaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lebeaux. The network helps show where David Lebeaux may publish in the future.
Co-authors
The 25 scholars most cited alongside David Lebeaux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2107 |
| 2 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 1757 |
| 3 | Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics Hit paper breakdown → | 2014 | 1076 |
| 4 | ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014 Hit paper breakdown → | 2015 | 669 |
| 5 | 2020 | 599 | |
| 6 | 2013 | 443 | |
| 7 | Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study Hit paper breakdown → | 2024 | 312 |
| 8 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 290 |
| 9 | 2021 | 258 | |
| 10 | 2021 | 232 | |
| 11 | 2013 | 214 | |
| 12 | Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study Hit paper breakdown → | 2016 | 196 |
| 13 | 2010 | 151 | |
| 14 | 2013 | 142 | |
| 15 | 2017 | 134 | |
| 16 | 2014 | 133 | |
| 17 | 2011 | 130 | |
| 18 | How do I manage nocardiosis? Hit paper breakdown → | 2021 | 128 |
| 19 | 2014 | 121 | |
| 20 | 2018 | 112 |
About David Lebeaux
David Lebeaux is a scholar working on Microbiology, Emergency Medical Services, Infectious Diseases, Epidemiology and Molecular Medicine, having authored 165 papers that have together received 11.8k indexed citations. Recurring topics across this work include Actinomycetales infections and treatment (33 papers), Central Venous Catheters and Hemodialysis (24 papers), COVID-19 Clinical Research Studies (15 papers), Bacterial biofilms and quorum sensing (15 papers), Infective Endocarditis Diagnosis and Management (9 papers), Antibiotic Resistance in Bacteria (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Microbiology (815 citations), Infectious Diseases (4.5k citations), Immunology (1.4k citations), Emergency Medical Services (364 citations) and Molecular Medicine (354 citations). David Lebeaux has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Christophe Beloin, Jean‐Marc Ghigo, Ashwini Chauhan, Olaya Rendueles, Olivier Lortholary, D. Sène, Claus Ernst Moser, Klaus Kirketerp‐Møller, Andrew J. Ullmann and Thomas Bjarnsholt. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Clinical Microbiology and Infection, European Journal of Clinical Microbiology & Infectious Diseases and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.